Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabi Öhm

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Neurological Disorders|July 2, 2016
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot studyThomas Müller, Thomas Herrling, Sven Lütge, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2025
Olfaction function improves in a specialised unit for Parkinson's diseaseThomas Müller, Gabi Öhm, Kathrin Eilert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 2, 2017
Benefit on motor and non-motor behavior in a specialized unit for Parkinson's diseaseThomas Müller, Gabi Öhm, Kathrin Eilert, et al.
Clinical Neuropharmacology|January 18, 2014
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosisThomas Müller, Thomas Herrling, Sven Lütge, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 12, 2014
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patientsThomas Müller, Stefan Barghorn, Sven Lütge, et al.
Journal of the Neurological Sciences|April 16, 2026
Instrumental assessment of movement series reflects scored improvement of patients with Parkinson's diseaseThomas Müller, Gabi Öhm, Raphaela Borowka, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Neurological Disorders|July 2, 2016
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot studyThomas Müller, Thomas Herrling, Sven Lütge, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2025
Olfaction function improves in a specialised unit for Parkinson's diseaseThomas Müller, Gabi Öhm, Kathrin Eilert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 2, 2017
Benefit on motor and non-motor behavior in a specialized unit for Parkinson's diseaseThomas Müller, Gabi Öhm, Kathrin Eilert, et al.
Clinical Neuropharmacology|January 18, 2014
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosisThomas Müller, Thomas Herrling, Sven Lütge, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 12, 2014
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patientsThomas Müller, Stefan Barghorn, Sven Lütge, et al.
Journal of the Neurological Sciences|April 16, 2026
Instrumental assessment of movement series reflects scored improvement of patients with Parkinson's diseaseThomas Müller, Gabi Öhm, Raphaela Borowka, et al.
Pageof 1